Skip to main content
. Author manuscript; available in PMC: 2023 Apr 10.
Published in final edited form as: Neurocrit Care. 2022 Mar 14;37(Suppl 2):322–327. doi: 10.1007/s12028-022-01470-x

Table 2.

Characteristics of Patients from Institution 1 and Institution 2, stratified by seizure occurrence

Institution 1 Institution 2
Variable No seizure N=582 Seizure N=52 P No seizure N=207 Seizure N=23 P
N (%) or median [IQR] N (%) or median [IQR]
Age <65 290 (49.8) 26 (50.0) 1 120 (58.0) 14 (60.9) 1
ICH Volume ( > 10 mL) 341 (58.6) 35 (67.3) 0.3 119 (57.5) 18 (78.3) 0.09
Hematoma Location (Cortical) 200 (34.4) 34 (65.4) <0.001 51 (24.6) 13 (56.5) 0.003
Anti-coagulant Use 71 (12.2) 11 (21.2) 0.1 17 (8.2) 5 (21.7) 0.09
Antiplatelet Use 190 (32.6) 22 (42.3) 0.2 75 (36.2) 9 (39.1) 1
GCS 0.02 0.07
13–15 326 (56.0) 18 (34.6) 128 (61.8) 7 (30.4)
5–12 183 (31.4) 28 (53.8) 52 (25.1) 12 (52.2)
3–4 73 (12.5) 6 (11.5) 27 (13.0) 4 (17.4)
INR 1.1 [1.0–1.2] 1.1 [1.0–1.4] 0.1 1.1 [1.0–1.1] 1.1 [1.0–1.6] 0.3
Initial SBP 175 [145–211] 163 [144–201] 0.07 192 [160–220] 175 [144–210] 0.08

GCS: Glasgow Coma scale, INR: international normalized ratio, SBP: systolic blood pressure